211 related articles for article (PubMed ID: 10846098)
1. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.
Doronin K; Kuppuswamy M; Toth K; Tollefson AE; Krajcsi P; Krougliak V; Wold WS
J Virol; 2001 Apr; 75(7):3314-24. PubMed ID: 11238857
[TBL] [Abstract][Full Text] [Related]
3. Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein.
Toth K; Tarakanova V; Doronin K; Ward P; Kuppuswamy M; Locke JE; Dawson JE; Kim HJ; Wold WS
Cancer Gene Ther; 2003 Mar; 10(3):193-200. PubMed ID: 12637940
[TBL] [Abstract][Full Text] [Related]
4. Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.
Shashkova EV; Spencer JF; Wold WS; Doronin K
Mol Ther; 2007 Mar; 15(3):598-607. PubMed ID: 17191072
[TBL] [Abstract][Full Text] [Related]
5. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS
Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAIL.
Shashkova EV; Kuppuswamy MN; Wold WS; Doronin K
Cancer Gene Ther; 2008 Feb; 15(2):61-72. PubMed ID: 17992200
[TBL] [Abstract][Full Text] [Related]
8. A fully replication-competent adenovirus vector with enhanced oncolytic properties.
Toth K; Kuppuswamy M; Shashkova EV; Spencer JF; Wold WS
Cancer Gene Ther; 2010 Nov; 17(11):761-70. PubMed ID: 20596091
[TBL] [Abstract][Full Text] [Related]
9. Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic Adenovirus.
Shashkova EV; Spencer JF; Wold WS; Doronin K
Mol Ther; 2007 Mar; 15(3):598-607. PubMed ID: 28182898
[TBL] [Abstract][Full Text] [Related]
10. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.
Tollefson AE; Scaria A; Hermiston TW; Ryerse JS; Wold LJ; Wold WS
J Virol; 1996 Apr; 70(4):2296-306. PubMed ID: 8642656
[TBL] [Abstract][Full Text] [Related]
11. An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling.
Toth K; Djeha H; Ying B; Tollefson AE; Kuppuswamy M; Doronin K; Krajcsi P; Lipinski K; Wrighton CJ; Wold WS
Cancer Res; 2004 May; 64(10):3638-44. PubMed ID: 15150123
[TBL] [Abstract][Full Text] [Related]
12. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants.
Tollefson AE; Ryerse JS; Scaria A; Hermiston TW; Wold WS
Virology; 1996 Jun; 220(1):152-62. PubMed ID: 8659107
[TBL] [Abstract][Full Text] [Related]
13. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
14. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
Yun CO; Kim E; Koo T; Kim H; Lee YS; Kim JH
Cancer Gene Ther; 2005 Jan; 12(1):61-71. PubMed ID: 15375379
[TBL] [Abstract][Full Text] [Related]
15. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO
Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236
[TBL] [Abstract][Full Text] [Related]
16. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
17. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
Wirth T; Zender L; Schulte B; Mundt B; Plentz R; Rudolph KL; Manns M; Kubicka S; Kühnel F
Cancer Res; 2003 Jun; 63(12):3181-8. PubMed ID: 12810646
[TBL] [Abstract][Full Text] [Related]
18. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
20. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
